Dr. Fukumoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1329 Lusitana St
Ste 307
Honolulu, HI 96813Phone+1 808-524-6115Fax+1 808-528-1711
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2003 - 2006
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2000 - 2003
New York University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2001 - 2026
HI State Medical License 2006 - 2026
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- 18 citationsManagement of patients with higher risk myelodysplastic syndromesJon S. Fukumoto, Peter L. Greenberg
Critical Reviews in Oncology/hematology. 2005-11-01 - 97 citationsRegulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein.Lucia Gabriele, Jon Fukumoto, David J. Segal, I-Ming Wang, Paraskevi Giannakakou
The Journal of Experimental Medicine. 1999-08-02 - 7 citationsNatural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan.D. Lynne Smith, Jie Cai, Sutao Zhu, Jon Fukumoto, Sanjai Sharma
International Journal of Cancer. 2003-09-10
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
